Sandoz Group Past Earnings Performance
Past criteria checks 1/6
Sandoz Group's earnings have been declining at an average annual rate of -18.6%, while the Pharmaceuticals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 0.4% per year. Sandoz Group's return on equity is 0.9%, and it has net margins of 0.8%.
Key information
-18.6%
Earnings growth rate
-90.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 16.3% |
| Revenue growth rate | 0.4% |
| Return on equity | 0.9% |
| Net Margin | 0.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Sandoz Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 9,979 | 77 | 2,389 | 926 |
| 30 Sep 23 | 9,770 | 345 | 2,315 | 899 |
| 30 Jun 23 | 9,561 | 613 | 2,241 | 871 |
| 31 Mar 23 | 9,434 | 731 | 2,184 | 852 |
| 31 Dec 22 | 9,306 | 848 | 2,127 | 833 |
| 31 Dec 21 | 9,678 | 908 | 2,127 | 911 |
| 31 Dec 20 | 9,658 | 462 | 2,132 | 873 |
Quality Earnings: SDZ has high quality earnings.
Growing Profit Margin: SDZ's current net profit margins (0.8%) are lower than last year (9.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SDZ's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: SDZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SDZ had negative earnings growth (-90.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-7.4%).
Return on Equity
High ROE: SDZ's Return on Equity (0.9%) is considered low.